Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination

Reverse ABO grouping reagent red blood cell kits use pre-characterized red blood cells to identify a patient’s blood group by detecting antibodies in their serum. Clinicians rely on these tests to confirm ABO compatibility before transfusions, ensuring safe blood administration by detecting naturally occurring anti-A and anti-B antibodies through agglutination reactions.

These kits are typically classified as in vitro diagnostics (IVDs) and are regulated based on their risk level, often requiring compliance with standards like ISO 15189 or FDA 21 CFR Part 820. They are commonly supplied as ready-to-use reagents in kits, designed for laboratory use in blood banks or clinical testing settings.